Join Us for Coffee & more This Pain Awareness Month

Join Us for Coffee & more This Pain Awareness Month

src="https://akusociety.org/wp-content/uploads/2025/11/september-newsletter-web-version.pdf" width="100%" height="876px" style="border: none;" This browser does not support PDF viewing within the page. You can download or view the PDF in a new...
Chris’s Story: Bringing AKU Awareness to the Football Pitch

Chris’s Story: Bringing AKU Awareness to the Football Pitch

Raising awareness of Alkaptonuria (AKU) is at the heart of what we do at the AKU Society. As a rare condition, AKU is often misunderstood or overlooked. This lack of awareness can delay diagnosis, limit support, and leave patients feeling isolated. That is why patient...
New PhD Launch, FDA Milestone, & Pain Awareness Ahead

New PhD Launch, FDA Milestone, & Pain Awareness Ahead

src="https://akusociety.org/wp-content/uploads/2025/11/AKU-August-Update_-New-PhD-Launch-FDA-Milestone-Pain-Awareness-Ahead.pdf" width="100%" height="876px" style="border: none;" This browser does not support PDF viewing within the page. You can download or view the...
Beyond the Biology: The Emotional Landscape of AKU

Beyond the Biology: The Emotional Landscape of AKU

Alkaptonuria (AKU) is a rare genetic condition that affects 1 in 250,000 to 500,000 people globally. Caused by a missing enzyme that breaks down a substance called homogentisic acid (HGA), AKU leads to the darkening of bones and cartilage, and can cause joint damage,...
New PhD Launch, FDA Milestone, & Pain Awareness Ahead

FDA Approval, Journal Spotlight and more

src="https://akusociety.org/wp-content/uploads/2025/11/New-in-AKU-News_-FDA-Approval-Journal-Spotlight-and-more-A0-size-1.pdf#toolbar=0&navpanes=0&scrollbar=0" width="100%" height="700px" style="border: none;"Download or view the PDF in a new...